03:42 PM EST - Immunovaccine Inc. : announced its intention to complete a non-brokered private placement of at least eight million common shares of the Company at a price of $0.40 per Common Share for minimum gross proceeds of $3.2 million. The Offering is expected to close on or about November 15, subject to the satisfaction of all necessary regulatory approvals, as well as to the satisfaction of customary closing conditions. Immunovaccine Inc.
shares V.IMV are trading up $0.01 at $0.45.
